Doctor of Medical Sciences
Department of Myocardial Pathology
H-index: RSCI 10, Scopus 5, Web of Science 4
Articles
-
Mochula A.V., Kopeva K.V., Maltseva A.N., Grakova E.V., Gulya M., Smorgon A.V., Gusakova A., Zavadovsky K.V. The myocardial flow reserve in patients with heart failure with preserved ejection fraction. Heart and Vessels 2023;38(3):348-360.
-
Kopeva K.V., Grakova E.V., Шилов С.Н., Berezikova E.N., Bobyleva E.T., Teplyakov A.T. Tetranectin as a potential novel prognostic biomarker in anthracycline-related cardiac dysfunction. Heart and Vessels 2023;38(10):1 256-1 266.
-
Yakovlev A., Teplyakov А., Grakova E., Shilov S., Yakovleva N., Kopeva K., Shirinsky I., Shirinsky V. Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study. Life 2023;13(3):1-11.
-
Kopeva K.V., Mochula A.V., Maltseva A.N., Soldatenko M.V., Grakova E.V., Zavadovsky K.V. Prognostic role of dynamic CZT imaging in heart failure with preserved ejection fraction. Clinical Nuclear Medicine 2023;48(8):364-370.
-
Grakova E.V., Shilov S.N., Kopeva K.V., Berezikova E.N., Popova A.A., Neupokoeva M.N., Ratushnyak E.T., Teplyakov A.T. Extracellular matrix remodeling in patients with anthracycline-induced heart failure: what place on the pedestal?. International Journal of Cardiology 2022;350:55-61.
-
Neglia D., Liga R., Gimelli A., Podlesnikar T., Cvijić M., Pontone G., Haertel Miglioranza M., Igoren Guaricci A., Seitun S., Clemente A., Sumin A., Vitola J., Saraste A., Paunonen Ch., Sia Ch-H., Paleev F., Elif Sade L., Zamorano J.L., Maroz-Vadalazhskaya N., Anagnostopoulos C., Macedo F., Knuuti J., Edvardsen Th., Cosyns B., Petersen S. E., Magne J., Laroche C., Berlè C., Popescu B.A., Delgado V., Zavadovsky K.V., Boshchenko A.A., Kopeva K.V., Mochula A.V., Maltseva A.N., Grakova E.V. Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry. European Heart Journal 2022; :1-18.
-
Kopeva K.V., Grakova E.V., Shilov S.N., Berezikova E.N., Popova A.A., Neupokoeva M.N., Ratushnyak E.T., Teplyakov A.T. The human hypoxia-inducible factor 1alpha gene in anthracycline-induced heart failure. Cor et Vasa 2022;64(4):390-397.
-
Grakova E.V., Kopeva K.V., Isakov L., Tarasov N., Sinkova M., Teplyakov A.T. Association of Galactin-3 as Predictor of Risk of Ventricular Tachycardia in Heart Failure Patients with Prior Implantable Cardioverter-Defibrillator. World Heart Journal 2022;14(1):42-48.
-
Grakova E.V., Shilov S.N., Kopeva K.V., Berezikova E.N., Popova A.A., Neupokoeva M.N., Ratushnyak E.T., Teplyakov A.T. Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction. Cardiology 2021;3(146):315-323.
-
Kopeva K.V., Grakova E.V., Shilov S.N., Berezikova E.N., Popova A.A., Neupokoeva M.N., Ratushnyak E.T., Teplyakov A.T. Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors. Acta Cardiologica 2021; :1-10.
-
Ефремов А.В., Шилов С.Н., Березикова Е.Н., Попова А.А., Сабирова А.Ю., Тепляков А.Т., Гракова Е.В., Торим Ю.Ю., Узакова А.О. Патогенетическая и прогностическая значимость фактора роста эндотелия сосудов в развитии хронической сердечной недостаточности. Здравоохранение Кыргызстана 2018; :12-18.
-
Anfinogenova Y., Grakova E.V., Shvedova M., Kopieva K.V., Teplyakov A.T., Popov S.V. Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure. Heart Failure Reviews 2018;23:481-497.